Indication (pathologie):
Renal insufficiency
Identifiant SNOMED-CT:
SCTID 723188008
Etudes cliniques
-
Inhibition du facteur Xa chez les patients insuffisants rénaux atteints de fibrillation auriculaire non valvulaire - Registre observationnel - Registre XARENOIndication (pathologie):Atrial FibrillationIdentifiant SNOMED-CT:SCTID 49436004Recrutement: Ouvert
-
Factor XA-inhibition in renal patients with non-valvular atrial fibrillation observational registryIndication (pathologie):Atrial FibrillationIdentifiant SNOMED-CT:49436004Recrutement: Ouvert
-
A randomised controlled trial of Rivaroxaban for the prevention of major cardiovascular events in patients with coronary or peripheral artery disease (COMPASS- Cardiovascular OutcoMes for People using Anticoagulation StrategieS) - Long-Term Open-Label Extension (LTOLE).Indication (pathologie):Thromboembolie veineuseIdentifiant SNOMED-CT:SCTID: 429098002Phase de l'étude: Phase IIIRecrutement: Fermé
-
Non-interventional study on edoxaban treatment in routine clinical practice in patients with venous thromboembolism in Europe (ETNA-VTE-Europe)Indication (pathologie):Thromboembolie veineuseIdentifiant SNOMED-CT:SCTID: 429098002Recrutement: Ouvert
-
Criteria for hospitalization or outpatient management of patients with pulmonary embolism, Hestia rule versus simplified PESI score : an open-label controlled randomized international trial (HOME-PE)Indication (pathologie):Embolie pulmonaireIdentifiant SNOMED-CT:SCTID: 59282003Recrutement: Ouvert
-
A phase 1b, randomized, double-blind, placebo-controlled, multi-center, single-ascending dose study to assess the safety, efficacy, pharmacokinetics, and pharmacodynamics of DS-1040b when added to standard of care anticoagulation therapy in subjects with acute submassive pulmonary embolismIndication (pathologie):Embolie pulmonaireIdentifiant SNOMED-CT:SCTID: 59282003Phase de l'étude: Phase IIRecrutement: Ouvert
-
Characterization of patients following acute venous thromboembolism (VTE) and safety and effectiveness of dabigatran etexilate (DE) in the treatment and secondary prevention of acute deep vein thrombosis (DVT) and pulmonary embolism (PE) in comparison to vitamin K antagonist (VKA) in routine clinical practiceIndication (pathologie):Maladie thromboembolique veineuseIdentifiant SNOMED-CT:SCTID: 429098002Recrutement: Fermé
-
An international, multicenter, randomized, double-blind, placebo controlled phase 3 trial investigating the efficacy and safety of rivaroxaban to reduce the risk of major thrombotic vascular events in patients with symptomatic peripheral artery disease undergoing lower extremity revascularization proceduresIndication (pathologie):Artériopathie périphériqueIdentifiant SNOMED-CT:SCTID: 399957001Phase de l'étude: Phase IIIRecrutement: Fermé
-
Global anticoagulant registry in the field observing treatment and outcomes in patients with treated acute venous thromboembolic events in the real worldIndication (pathologie):Thromboembolie veineuseIdentifiant SNOMED-CT:SCTID: 429098002Recrutement: Fermé
-
Recurrent venous thromboembolism risk stratification evaluation. Validation of the "Men and HERDOO2" - a clinical decision rule to identify patients with "unprovoked" venous thromboembolism who can discontinue anticoagulants after six months of treatmentIndication (pathologie):Thromboembolie veineuseIdentifiant SNOMED-CT:SCTID: 429098002Recrutement: Fermé
-
Edoxaban management in diagnostic and therapeutic procedures (EMIT-AF/VTEIndication (pathologie):Thromboembalie veineuseIdentifiant SNOMED-CT:SCTID: 429098002Phase de l'étude: Phase IVRecrutement: Fermé
-
A randomized controlled trial of rivaroxaban for the prevention of major cardiovascular events in patients with coronary or peripheral artery diseaseIndication (pathologie):CoronaropathieIdentifiant SNOMED-CT:53741008Indication (pathologie):Thromboembolie veineuseIdentifiant SNOMED-CT:SCTID: 429098002Recrutement: Fermé